Loading data
EDITNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 40.52 m USD | 32.31 m USD | 78.12 m USD | 19.71 m USD | 25.54 m USD |
| Research and development expense | 89.95 m USD | 199.25 m USD | 177.65 m USD | 174.96 m USD | 142.51 m USD |
| Operating profit | -160.01 m USD | -251.15 m USD | -169.18 m USD | -225.95 m USD | -193.15 m USD |
| Income tax expense | 0 USD | 0 USD | — | — | — |
| Net income (reported basis) | -160.06 m USD | -237.09 m USD | -153.22 m USD | -220.43 m USD | -192.5 m USD |
| Net income attributable to common shareholders | — | — | — | -220.43 m USD | -192.5 m USD |
| Basic earnings per share | -1.8 USD/share | -2.88 USD/share | -2.02 USD/share | -3.21 USD/share | -2.85 USD/share |
| Diluted earnings per share | -1.8 USD/share | -2.88 USD/share | -2.02 USD/share | -3.21 USD/share | -2.85 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.